Supplementary Material for: Effects of wearing hearing aids on gait and cognition: A pilot study حسب figshare admin karger (2628495)

"…Cognitive function, measured by Montreal Cognitive Assessment and delayed verbal recall on the logical memory test, also improved significantly at follow-up. Furthermore, reduced fear of falling and increased WHO-5 scores were observed after one year of HA use. …"

POm shows pronounced response disparity to active and passive whisker stimuli. حسب Anton Sumser (21021061)

"…Rate increase: 4/11 neurons, rate decrease: 1/11 neurons (light gray), non-significant: 6/11 neurons. …"

Robust chain-length specific reductions in intermediate chain phospholipids in peroxisomal mutant larvae. حسب Michael F. Wangler (21526595)

Update on trimethylamine N-oxide (TMAO) as a piezolyte and cryoprotectant: its role in a depth limit for marine fishes and loss from hadal fish during capture حسب Paul Yancey (14354982)

"…<p dir="ltr"><b>I</b><b>NTRODUCTION</b></p><p dir="ltr">Trimethylamine N-oxide (TMAO) is a small organic molecule found at osmotically-significant concentrations in many marine animal taxa. …"

Supplementary Material for: Trends in the Incidence of Rare Eyelid Malignancies: A SEER-Based Study (2000–2021) حسب figshare admin karger (2628495)

"…Gender was non-significant for all three cancers. Conclusion: Incidence of eyelid cancers revealed variable temporal trends, with a slight overall increase projected. …"

Caffeine induces proteome-wide changes in a Rob-dependent manner. حسب Christoph Binsfeld (21763112)

"…The double-sided Fisher’s exact test p-value for enrichment of OMPs among significantly decreased proteins is shown. (D) Comparison of proteome changes between wild type and Δ<i>rob</i> upon caffeine treatment. …"

Image 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial.tif حسب Huaxiang Liu (322464)

"…</p>Conclusion<p>Ivarmacitinib significantly reduces the need for adding/escalating medications compared to placebo, thereby potentially decreasing treatment burden. …"

Image 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Table 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Table 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Image 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Table 4_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Table 3_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Table 5_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... حسب Ulrike Gimsa (9730208)

"…The DU6 polygenic mouse line was selected over more than 180 generations for a high body mass. Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. …"

Supplementary file 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III tria... حسب Huaxiang Liu (322464)

"…</p>Conclusion<p>Ivarmacitinib significantly reduces the need for adding/escalating medications compared to placebo, thereby potentially decreasing treatment burden. …"

The in vitro and in vivo effect of a chemokine inhibitor CTCE-9908 in combination with Kynurenine metabolites on tumour adhesion حسب Danielle Tatchum (16946574)

"…In the non-cancerous cell lines HaCaT and EA. hy926, there was a decrease in percentage cell number after treatment with L-kyn, phorbol 12-myristate 13-acetate (PMA), a positive control for adhesion, and CTCE-9908, suggesting a decrease in cell adhesion in the non-cancerous cell lines.…"

Flowchart of the study. حسب Flavia Furlaneto (20161022)

"…Differences between therapeutic groups were analyzed by non-parametric tests (<i>p</i><0.05).</p><p>Results</p><p>The Placebo and Probiotic groups showed a significant reduction in BOMP at 8 weeks compared to baseline (p<0.05). …"

Association of Patient Cost-Sharing with Adherence to GLP-1a and Adverse Health Outcomes حسب Donglan Zhang (702608)

"…<p dir="ltr">Objective To examine the associations between patient out-of-pocket (OOP) costs and non-adherence to glucagon-like peptide-1 receptor agonists (GLP-1a), and the consequent impact on adverse outcomes including hospitalizations and emergency department (ED) visits. …"

Table 1_Is there a link between motor learning and mirror neuron system: TMS study.docx حسب Ekaterina Pomelova (22177021)

"…We found a significant correlation between the learning speed of the non-dominant hand and mirror neuron activation in the dominant hemisphere during the observation of button presses and pinch gestures.…"

Robust chain-length specific elevations in long chain phospholipids in peroxisomal mutant larvae. حسب Michael F. Wangler (21526595)

"…For PC 38:2, <i>pex2</i> mutant larvae compared to <i>pex2</i> rescue (ratio <i>pex2/pex2</i> rescue: ratio 2.303,p = 0.0426), and a non-significant decrease in <i>pex16</i> mutant larvae compared to <i>pex16</i> rescue (<i>pex16/pex16</i> rescue: ratio 3.243, p = 0.0193).…"